Clinical outcomes of "complete, partially complete, and incomplete" revascularisation at five-year follow-up after percutaneous intervention of unprotected left main XXXX with @entity734 .

@entity1 @entity583 @entity1939 @entity299 @entity453 @entity204 @entity734
AIMS: The study aimed to examine five-year clinical outcomes of complete (CR), partially complete (PCR), and incomplete revascularisation (ICR) in @entity1 with unprotected left main @entity453 treated with @entity734 ( @entity734 ). @entity1939 , defined as revascularisation of all vessels >= 1.5 or 2.5 mm in diameter, has been shown to correlate with outcomes after percutaneous coronary intervention (PCI). There are no data to compare revascularisation strategies on long-term clinical outcomes in @entity1 undergoing PCI of @entity453 . METHODS AND RESULTS: This prospective registry enrolled 910 consecutive @entity1 with @entity453 undergoing PCI with @entity734 implantation. CR included @entity1 who had a successful revascularisation of all diseased segments with diameter >= 1.5 mm. PCR included @entity1 who had successful revascularisation of all diseased segments with diameter >= 2.5 mm. ICR included @entity1 who did not achieve revascularisation for all diseased segments of diameter >= 2.5 mm. The primary endpoint was the incidence of major adverse @entity299 (MACE: a composite of @entity204 , @entity583 and repeat revascularisation) at five-year follow-up. CR was achieved in 386 (42.4%), PCR in 227 (25.0%), and ICR in 297 (32.6%) @entity1 . @entity1 with ICR had a significantly higher rate of MACE (29.6% vs. 22.5% and 15.5%, p<0.001) and all-cause mortality (12.5% vs. 7.0% and 6.2%; p=0.006) than those with CR and PCR at five-year follow-up. After propensity score matching, @entity1 with CR vs. PCR had similar incidences of MACE (hazard ratio [HR]: 1.16, 95% confidence interval [CI]: 0.78-1.74, p=0.46), mortality (HR: 1.27, 95% CI: 0.61-2.63, p=0.53), and @entity204 (1.8% vs. 4.5%; HR: 2.56, 95% CI: 0.80-8.17, p=0.11). On multivariable logistic regression analysis, ICR appears to be an outcome of poor clinical characteristics, comorbidities and complex coronary anatomy. CONCLUSIONS: In the treatment of @entity1 with @entity453 , ICR was associated with worse long-term clinical outcomes than CR and PCR. PCR has clinical outcomes similar to CR in @entity1 with @entity453 treated with @entity734 .
